Company Biomedica Group Srl with Fiscal Code 16471861
recorded a turnover of 2024 of
442.222,
with a net profit of
13.098
and having an average number of employees of
19.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Biomedica Group Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
102.878
129.874
151.486
185.865
199.709
203.604
323.124
290.870
436.620
442.222
Total Income - EUR
103.137
130.300
155.373
187.507
200.447
210.152
333.188
292.372
448.452
444.985
Total Expenses - EUR
102.603
128.686
144.553
183.917
191.780
179.189
289.254
286.418
348.021
420.547
Gross Profit/Loss - EUR
535
1.613
10.820
3.590
8.668
30.963
43.934
5.954
100.432
24.438
Net Profit/Loss - EUR
163
859
4.652
1.715
6.669
29.037
41.002
3.471
96.326
13.098
Employees
9
6
9
8
9
7
12
18
18
19
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 1.9%, from 436.620 euro in the year 2023, to 442.222 euro in 2024.
The Net Profit decreased by -82.689 euro, from 96.326 euro in 2023, to 13.098 in the last year.
Check the financial reports for the company - Biomedica Group Srl
Financial Rating - BIOMEDICA GROUP SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Biomedica Group Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Biomedica Group Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Biomedica Group Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Biomedica Group Srl - CUI 16471861
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
116.869
117.270
140.860
152.521
134.929
125.185
165.380
189.065
329.874
484.687
Current Assets
39.082
32.049
29.790
34.422
38.950
64.753
100.309
74.129
103.130
74.486
Inventories
10.561
1.167
7.027
9.435
11.946
11.810
14.215
18.392
44.119
59.113
Receivables
23.559
21.895
11.714
10.981
11.785
3.136
16.323
7.449
21.053
3.850
Cash
4.963
8.987
11.049
14.006
15.219
49.807
69.771
48.287
37.958
11.522
Shareholders Funds
89.200
89.149
92.293
92.314
92.983
120.257
158.592
156.471
236.500
245.563
Social Capital
45
45
44
43
44
43
42
43
42
42
Debts
66.751
61.264
78.357
94.630
80.896
69.681
107.097
106.723
196.504
313.611
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8622 - 8622"
CAEN Financial Year
8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
74.486 euro in 2024 which includes Inventories of
59.113 euro, Receivables of
3.850 euro and cash availability of
11.522 euro.
The company's Equity was valued at
245.563 euro, while total Liabilities amounted to
313.611 euro.
Equity increased by 10.384 euro, from 236.500 euro in 2023, to 245.563 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Biomedica Group Srl